16-74691297-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_152649.4(MLKL):āc.702A>Gā(p.Lys234=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000933 in 1,598,684 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0023 ( 3 hom., cov: 31)
Exomes š: 0.00080 ( 21 hom. )
Consequence
MLKL
NM_152649.4 synonymous
NM_152649.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.02
Genes affected
MLKL (HGNC:26617): (mixed lineage kinase domain like pseudokinase) This gene belongs to the protein kinase superfamily. The encoded protein contains a protein kinase-like domain; however, is thought to be inactive because it lacks several residues required for activity. This protein plays a critical role in tumor necrosis factor (TNF)-induced necroptosis, a programmed cell death process, via interaction with receptor-interacting protein 3 (RIP3), which is a key signaling molecule in necroptosis pathway. Inhibitor studies and knockdown of this gene inhibited TNF-induced necrosis. High levels of this protein and RIP3 are associated with inflammatory bowel disease in children. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-74691297-T-C is Benign according to our data. Variant chr16-74691297-T-C is described in ClinVar as [Benign]. Clinvar id is 716578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.02 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00227 (337/148494) while in subpopulation AMR AF= 0.0186 (278/14908). AF 95% confidence interval is 0.0168. There are 3 homozygotes in gnomad4. There are 184 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MLKL | NM_152649.4 | c.702A>G | p.Lys234= | synonymous_variant | 4/11 | ENST00000308807.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MLKL | ENST00000308807.12 | c.702A>G | p.Lys234= | synonymous_variant | 4/11 | 2 | NM_152649.4 | P1 | |
MLKL | ENST00000306247.11 | c.535+1045A>G | intron_variant | 1 | |||||
MLKL | ENST00000571303.1 | c.174A>G | p.Lys58= | synonymous_variant, NMD_transcript_variant | 1/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00228 AC: 338AN: 148378Hom.: 3 Cov.: 31
GnomAD3 genomes
AF:
AC:
338
AN:
148378
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00333 AC: 812AN: 243870Hom.: 13 AF XY: 0.00263 AC XY: 347AN XY: 132126
GnomAD3 exomes
AF:
AC:
812
AN:
243870
Hom.:
AF XY:
AC XY:
347
AN XY:
132126
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000796 AC: 1154AN: 1450190Hom.: 21 Cov.: 31 AF XY: 0.000687 AC XY: 496AN XY: 721496
GnomAD4 exome
AF:
AC:
1154
AN:
1450190
Hom.:
Cov.:
31
AF XY:
AC XY:
496
AN XY:
721496
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00227 AC: 337AN: 148494Hom.: 3 Cov.: 31 AF XY: 0.00254 AC XY: 184AN XY: 72336
GnomAD4 genome
AF:
AC:
337
AN:
148494
Hom.:
Cov.:
31
AF XY:
AC XY:
184
AN XY:
72336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at